Elvie, a leader in consumer health devices, is stepping into the digital health arena with the launch of Elvie Strong, a free app designed to support pelvic floor health. This is Elvie’s first venture into purely digital solutions, aiming to make health and wellness more accessible for women. Pelvic floor muscles are vital for overall health, impacting bladder control and sexual function.…
Amber Therapeutics, a UK-based medical technology company, has successfully closed a $100 million Series A financing round. The investment will advance their Amber-UI neuromodulation therapy towards US FDA approval. The financing round, one of the largest ever in Europe for a medical technology company, was led by New Enterprise Associates (NEA) with participation from F-Prime Capital, Lightstone Ventures, Intuitive Ventures, and existing…
Researchers from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the University of California Davis have developed a human Cervix-on-a-Chip. This model accurately mimics the complex cervical tissue and addresses the limitations of current animal and in vitro models, enhancing the study of bacterial vaginosis (BV) and fostering the development of more effective treatments. Bacterial Vaginosis affects over 25%…
Axena Health, a medical device company dedicated to advancing female pelvic health, has successfully raised an additional $9.4 million in its Series A fundraising round. This latest tranche of funding saw participation from Cross-Border Impact Ventures (CBIV) alongside existing investors such as AXA IM Alts through its Global Healthcare Private Equity Strategy, KOFA Healthcare, and Avestria Ventures. As part of the investment,…
Nanopath, a point-of-care diagnostics company, has received $4 million in federal grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF). This funding is intended to support the development of Nanopath’s diagnostic platform, which focuses on pelvic and gynecologic infections and diseases. The grants were awarded through the competitive Small Business Innovation Research (SBIR) Program. The total federal…
Watkins-Conti, a women’s health company dedicated to advancing pelvic health solutions, has achieved a significant milestone with the FDA 510(k) clearance for its device, Yōni.Fit Bladder Support. Designed and manufactured in the U.S. using 100% medical-grade silicone, Yōni.Fit represents a new approach to addressing SUI without resorting to surgery. The device, designed as a soft vaginal insert, effectively reduces urine leaks while…
TiumBio, a clinical-stage biopharmaceutical company based in South Korea, recently unveiled encouraging findings from its Phase 2a clinical trial of Merigolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, aimed at alleviating moderate to severe endometriosis-associated pain. This announcement comes on the heels of a successful $12 million funding round, earmarked to advance the company’s clinical pipeline. The Phase 2a trial showcased promising…
An extensive evaluation conducted by Health Innovation Kent Surrey Sussex (part of the Health Innovation Network), in collaboration with MUTU Systems and Unity Insights, showed substantial impact of the MUTU System in addressing postpartum pelvic health symptoms within the NHS. Postpartum pelvic health remains an underserved area within women’s healthcare, with many women experiencing long-term conditions impacting their well-being. However, reluctance to…
